Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FESOTERODINE FUMARATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for FESOTERODINE FUMARATE EXTENDED-RELEASE TABLETS. FESOTERODINE FUMARATE extended-release tablets, for oral use Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
Fesoterodine fumarate extended-release tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. Pediatric use information is approved for Pfizer Inc.'s TOVIAZ® (fesoterodine fumarate) Extended-Release Tablets. However, due to Pfizer Inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
- generic_name
- fesoterodine fumarate
- product_names
- Fesoterodine Fumarate
- ndc
- 67877-064, 67877-068, 67877-064-30, 67877-064-90, 67877-068-30, 67877-068-90
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en